Hey everyone, I just thought you might be interested in this blog post below about electronic health records (EHRs.), and how beneficial they could with cancer treatment.
As you know, patients must often visit multiple doctors and try several different treatment options. Given the complications of this disease and the number of people touched by it, it makes sense to have patient health information stored electronically in one, secure place. EHRs help patients get the best care possible.
In one recent example, Heidi Sitcov, a nurse and daughter of a father with cancer, felt she was given four more years of quality time with him after he was diagnosed than doctors predicted because she found a doctor who used EHRs for patient care. Heidi shares her personal story about the vital role EHRs played in improving the care her father received, and how EHRs lessened her family’s stress as caregivers in the wake of her father’s life-changing diagnosis on the Health IT Buzz, the official blog of the Office of the National Coordinator for Health Information Technology.
You can read more about her story and her family’s experience with EHRs here. www.cancercompass.com
Reuters - Looking stronger after cancer treatment, Venezuela's President Hugo Chavez said on Thursday he felt reborn, phoenix-like, on his 57th birthday, in a sign the socialist believes he is overcoming his illness. us.rd.yahoo.com
Among young women receiving chemotherapy for early-stage breast cancer, use of a drug that suppresses ovarian function may reduce the risk of early menopause. These results were published in the Journal of the American Medical Association.
Roughly six percent of women with breast cancer are diagnosed before the age of 40. Many of these women are treated with chemotherapy and/or hormonal therapy and are at risk of early menopause as a result of treatment. Consequences of early menopause include infertility and symptoms such as hot flashes.
Young women with cancer who wish to preserve their fertility may be able to freeze embryos, eggs, or ovarian tissue before cancer treatment begins. Protection of the ovaries during treatment may also help to preserve ovarian function and fertility, but there have been no standard strategies for preventing chemotherapy-induced ovarian failure.
Drugs known as gonadotropin-releasing hormone (GnRH) analogues suppress ovarian function. In order to assess whether use of one of these drugs (triptorelin) during chemotherapy protects the ovaries from chemotherapy-induced damage, researchers conducted a Phase III clinical trial. The study enrolled 281 premenopausal women with Stage I through Stage III breast cancer. All study participants were candidates for chemotherapy.
Study participants were assigned to receive chemotherapy alone or in combination with triptorelin. For women in the triptorelin group, triptorelin was given at least one week prior to the start of chemotherapy and then every four weeks during chemotherapy.
The primary outcome of interest was early menopause. This was defined as postmenopausal hormone levels and no resumption of menstrual cycles one year after the last cycle of chemotherapy.
One year after the last cycle of chemotherapy, the rate of early menopause was 26% among women in the chemotherapy-alone group and 9% among women in the chemotherapy-plus-triptorelin group.
A potential concern with this approach is that preservation of ovarian function could increase risk of recurrence among women with hormone receptor-positive breast cancer. To address this concern, study participants with hormone receptor-positive breast cancer and resumption of ovarian function (as evidenced by a menstrual cycle or premenopausal hormone levels) were put back on triptorelin until the ovaries had been suppressed for at least two years. Study participants with hormone receptor-positive breast cancer also received tamoxifen for five years.
This study suggests that use of a GnRH analogue during chemotherapy may reduce the risk of early menopause among young women with breast cancer. The study did not, however, address the impact of GnRH use on breast cancer outcomes.
Young breast cancer patients who wish to preserve their fertility and/or ovarian function are advised to discuss the available options with their physician before treatment begins.
Reference: Del Mastro L, Boni L, Michelotti A et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer. A randomized trial. Journal of the American Medical Association. 2011;306:269-276. news.cancerconnect.com
question by jayjay : What are the early signs of lung cancer
I hope you can tell from your story personnelle.Mon husband is not a smoker, but a sheriff’s deputy and spent much time in prison. It is currently being tested for lung cancer since they found several black spots on its poumons.Quelqu one wants to share their personal stories of their “first” symptoms and what they were? Best Answer “strong >:
by Eddie Cacciatore, Private Eye I’m sorry to hear. My mother’s breathing was compromised. Less energy. There are a smoker to work with a cough will not go away. I bet she is a candidate.
give your answer to this question below!
Cancer HealthQ & A: What are the early signs of lung cancer?Lung cancer: causes, symptoms, signs, diagnosis, treatments, courses. What you need to know about lung cancerCelebrex may prevent lung cancer among former smokers, early studies suggestQ & A: Is it rare to get lung cancer at an early age?The symptoms of lung cancer – Signs and symptoms of cancer of GeneralProstate Cancer Treatment – How to Detect Early Signs www.newhealthidea.com
You can link to this article on your web site using following code:
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.